Gilead Sciences Stock
StockStockPrice
Historical dividends and forecast
Gilead Sciences has so far distributed $2.31 in 2024. The next dividend will be paid on 28.12.2024
CHART BY
Frequently asked questions
What is Gilead Sciences's market capitalization?
What is Gilead Sciences's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Gilead Sciences?
What are the analyst ratings and target price for Gilead Sciences's stock?
What is Gilead Sciences's revenue over the trailing twelve months?
What is the EBITDA for Gilead Sciences?
What is the free cash flow of Gilead Sciences?
What is the 5-year beta of Gilead Sciences's stock?
How many employees does Gilead Sciences have, and what sector and industry does it belong to?
What is the free float of Gilead Sciences's shares?
Financials
Market Cap
$109.92B5Y beta
0.20EPS (TTM)
$0.819Free Float
1.24BP/E ratio (TTM)
107.79Revenue (TTM)
$27.81BEBITDA (TTM)
$13.15BFree Cashflow (TTM)
$3.04BPricing
Analyst Ratings
The price target is $81.21 and the stock is covered by 29 analysts.
Buy
11
Hold
17
Sell
1
Information
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.
18,000
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker